IBAI — Imaging Biometrics Share News
0.000.00%
Last trade - 00:00- £1.95m
- £1.90m
- £0.79m
Imaging Biometrics - Half Yearly Report to 30 June 2026
Imaging Biometrics - Sub-division
Brief: Imaging Biometrics Says Oral Gallium Maltolate Safe And Well Tolerated Up To 2500 Mg/Day
Brief: Imaging Biometrics Says Expectation Of Progress Towards Profitability In 2026 Is Unchanged
Imaging Biometrics - AGM Statement and Business Update
Imaging Biometrics - NOTICE OF ANNUAL GENERAL MEETING
Imaging Biometrics - KIRKSTALL AWARDED BBSRC/NC3Rs GRANT: GLIOBLASTOMA
Imaging Biometrics - Annual Report for the Year Ended 31 December 2025
Imaging Biometrics - Board Appointment
Imaging Biometrics - Update and IB Nimble Webinar – 27 February 2026
Brief: Imaging Biometrics Directors Decide Against Phase 2 Trial Of Gallium Maltolate
Imaging Biometrics - Expansion Global Distribution Agreement with GE
Imaging Biometrics - Release of Next-Generation IB Clinic
Imaging Biometrics - Board Changes
Imaging Biometrics - Fractional Tumor Burden Mapping Enhances GBM Trial
Brief: Imaging Biometrics Announces Completion Of Phase 1 Trial Of GaM
Imaging Biometrics - IB Announces Completion of Phase 1 Trial of GaM
Imaging Biometrics - Purchase of Kirkstall and CLN - Correction
Imaging Biometrics - Purchase of Kirkstall and CLN with Truetide plc